Research output per year
Research output per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Medicine, PhD, Immunotherapy for Advanced Melanoma, University of Melbourne
Award Date: 8 Dec 2021
Immunology, BSc (Hons), Murdoch University
28 Feb 2002 → 1 Dec 2002
Award Date: 15 Dec 2002
Medicine, MBBS, University of Queensland
Feb 2003 → Dec 2007
External positions
Medical Oncologist, Peter Maccallum Cancer Centre
1 Feb 2016 → 2021
Research expertise keywords
- Melanoma
- Breast cancer research
- Cancer research
- Immunotherapy
Fingerprint
Dive into the research topics where Peter Lau is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Melanoma brain metastases that progress on BRAF-MEK inhibitors demonstrate resistance to ipilimumab-nivolumab that is associated with the Innate PD-1 Resistance Signature (IPRES)
Lau, P. K. H., Feran, B., Smith, L., Lasocki, A., Molania, R., Smith, K., Weppler, A., Angel, C., Kee, D., Bhave, P., Lee, B., Young, R. J., Iravani, A., Yeang, H. A., Vergara, I. A., Kok, D., Drummond, K., Neeson, P. J., Sheppard, K. E. & Papenfuss, T. & 3 others, , 8 Oct 2021, In: Journal for ImmunoTherapy of Cancer . 9, 10, e002995.Research output: Contribution to journal › Article › peer-review
Open Access20 Citations (Scopus) -
Capecitabine for hormone receptor-positive versus hormone receptor-negative breast cancer
Hoon, S. N., Lau, P. K. H., White, A. M., Bulsara, M. K., Banks, P. D. & Redfern, A. D., 26 May 2021, In: Cochrane Database of Systematic Reviews. 2021, 5, CD011220.Research output: Contribution to journal › Review article › peer-review
Open Access9 Citations (Scopus) -
Adaptive translational reprogramming of metabolism limits the response to targeted therapy in BRAFV600 melanoma
Smith, L. K., Parmenter, T., Kleinschmidt, M., Kusnadi, E. P., Kang, J., Martin, C. A., Lau, P., Patel, R., Lorent, J., Papadopoli, D., Trigos, A., Ward, T., Rao, A. D., Lelliott, E. J., Sheppard, K. E., Goode, D., Hicks, R. J., Tiganis, T., Simpson, K. J. & Larsson, O. & 5 others, , Dec 2022, In: Nature Communications. 13, 1, 1100.Research output: Contribution to journal › Article › peer-review
Open Access14 Citations (Web of Science) -
Adult medulloblastoma in an Australian population
Parakh, S., Davies, A., Westcott, K., Roos, D., Abou-Hamden, A., Ahern, E., Lau, P. K. H., Cheruvu, S., Pranavan, G., Pullar, A., Lynam, J., Gzell, C., Whittle, J. R., Cain, S., Inglis, P. L., Harrup, R., Anazodo, A., Hovey, E., Cher, L. & Gan, H. K., Aug 2022, In: Journal of Clinical Neuroscience. 102, p. 65-70 6 p.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
Tissue-resident memory T cells in the era of (Neo) adjuvant melanoma management
Plunkett, K. R., Armitage, J. D., Inderjeeth, A. J., McDonnell, A. M., Waithman, J. & Lau, P. K. H., 16 Nov 2022, In: Frontiers in Immunology. 13, 1048758.Research output: Contribution to journal › Review article › peer-review
Open Access7 Citations (Scopus)
-
Establishing TIL therapy For Immunotherapy-Resistant Melanoma
Nilsson, J. (Investigator 01), Gray, E. (Investigator 02), Waithman, J. (Investigator 03) & Lau, P. (Investigator 04)
Cancer Research Trust, Wind Over Water, Wind Over Water Foundation
1/04/24 → 31/12/28
Project: Research
-
Hck in tumour associated macrophages: a novel drug target and a diagnostic tool for invasive triple negative breast cancer
Pixley, F. (Investigator 01), Ernst, M. (Investigator 02), Poh, A. (Investigator 03), Lau, P. (Investigator 04) & Dabner, M. (Investigator 05)
1/01/23 → 31/12/24
Project: Research
-
Novel insights into immune control of dormant tumours.
McDonnell, A. (Investigator 01), Lau, P. (Investigator 02), McCoy, M. (Investigator 03) & Armitage, J. (Investigator 04)
4/01/21 → 30/12/23
Project: Research